Skip to evidence report

IPSC.mesodermal_primed: Studies — page 8

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 7,001–8,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
7001DUSP29 levelsGCST904690520.36
7002SIGLEC8 levelsGCST900898860.36
7003Bone density Z-scoreGCST902786210.36
7004BSG/TNFRSF4 ratioGCST903135360.36
7005SOD1 levelsGCST904707040.36
7006CD84/CDKN1A ratioGCST903139090.36
7007C9 Carnitine levels in chronic kidney diseaseGCST902576820.36
7008CD300C/GOLM2 ratioGCST903137880.36
7009LPO levelsGCST902417300.36
7010FHIT/PMVK ratioGCST903148220.36
7011Processed meat intake | DietUKBB000007110.35
7012CHCHD10 levelsGCST904687380.35
7013CDC26 levelsGCST904686630.35
7014Central serous chorioretinopathyGCST902684000.35
7015Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759840.35
7016Basophil count varianceGCST905656820.35
7017Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478ECGA0004780.35
7018ITGAL levelsGCST904696370.35
7019AXIN1/HEXIM1 ratioGCST903134080.35
7020PCYT2 levelsGCST904701780.35
7021SERPINF2 levelsGCST904705990.35
7022IDP T1 SIENAX grey normalised volumeGCST900024300.35
7023ADAMTS15/SULT2A1 ratioGCST903131710.35
7024Concentration of LDL particles (UKB data field 23429)GCST902695260.35
7025Polycythemia, secondary (PheCode 289.8)GCST904758220.35
7026CSTB levelsGCST901792720.35
7027Retinal arteriolar tortuosityGCST902703970.35
7028Omega-3 fatty acid levelsGCST905020560.35
7029MPHOSPH8 levelsGCST904699340.35
7030Neuroticism score | Mental healthUKBB000004960.35
7031Cholelithiasis and cholecystitis | digestiveUKBB000001330.35
7032Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763700.35
7033Witnessed sudden violent death | Traumatic eventsUKBB000009170.35
7034LONP1 levelsGCST904697850.35
7035Macular puckerFING000007450.34
7036Type 2 diabetesGCST900860720.34
7037GBP4 levelsGCST904693130.34
7038Migraine without auraFING000008210.34
7039Continuous positive airway pressureFING000003490.34
7040Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025920.34
7041ITGB5 levelsGCST904696450.34
7042SERPINB6 levelsGCST904705910.34
7043ICD10 E28.2: Polycystic ovarian syndromeGCST904542050.34
7044OtosclerosisFING000011310.34
7045hematocrit (maximum, inv-norm transformed)GCST904753380.34
7046Concentration of VLDL particlesGCST905002460.34
7047ESAM/SCARF1 ratioGCST903147150.34
7048IL15/IL18BP ratioGCST903151480.34
7049F-cheese liking (derived food-liking factor)GCST900947290.34
7050SAP18 levelsGCST902414320.34
7051CNTN3 levelsGCST904688050.34
7052Aspartate aminotransferase (AST, minimum, inv-norm transformed)GCST904751240.34
7053Neutrophil countGCST900023520.34
7054HippSubfield lh volume hippocampal-fissureGCST900026720.34
7055ICAM3 levelsGCST904695000.34
7056IDS/SMPDL3A ratioGCST903151260.34
7057Volume of right cortico-amygdaloid transition areaGCST904749110.34
7058Bicarbonate (mean, inv-norm transformed)GCST904751480.34
7059C2/LILRB4 ratioGCST903135540.34
7060BMP6 levelsGCST904684540.34
7061Triglyceride levels in chylomicrons and extremely large VLDLGCST905010750.34
7062F-fatty/dairy food liking (derived food-liking factor)GCST900947600.34
7063HARS1 levelsGCST904694300.33
7064Chest pain or discomfort | Chest painUKBB000001280.33
7065Concentration of medium VLDL particles (UKB data field 23502)GCST902695990.33
7066KITLG levelsGCST904284320.33
7067Open-angle glaucoma (PheCode 365.1)GCST904758720.33
7068Other diseases of liverFING000010040.33
7069IGSF21 levelsGCST904695380.33
7070NT5C3A/SCRN1 ratioGCST903155690.33
7071FSTL1 levelsGCST904692710.33
7072Total lipid levels in medium LDLGCST900929100.33
7073SMOC1 levelsGCST904706820.33
7074Glycoprotein acetyls levelsGCST904973200.33
7075DTI TBSS L1 External capsule LGCST903844610.33
7076Treatment/medication code - bendroflumethiazide | MedicationsUKBB000008430.33
7077YTHDF3 levelsGCST904710910.33
7078Sleep apnoeaFING000013090.33
7079CELA3A/CTRC ratioGCST903140120.33
7080FAM171B levelsGCST900903390.33
7081ERBB4 levelsGCST904691410.33
7082Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755560.33
7083SHMT1 levelsGCST904706270.33
7084PSME2 levelsGCST904703610.33
7085CASP3/SNAP23 ratioGCST903136440.33
7086Active to sedentary transition probabilityGCST900614290.33
7087CALB1 levelsGCST904685260.33
7088T1 FreeSurfer a2009s lh G front sup thicknessGCST903847570.33
7089Glycoprotein acetyls levelsGCST900928210.33
7090CD79B/CKAP4 ratioGCST903138980.33
7091CirrhosisGCST900186060.32
7092Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903027220.32
7093HypertensionGCST900860920.32
7094Free cholesterol in medium HDL (UKB data field 23570)GCST902696670.32
7095CCL4 levelsGCST902747700.32
7096LAT2 levelsGCST904697390.32
7097MPIG6B levelsGCST904699350.32
7098ELAC1 levelsGCST904691010.32
7099Cholesteryl esters in large LDL (UKB data field 23534)GCST902696310.32
7100KLK6/MOG ratioGCST903152550.32
7101Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488ECGA0004880.32
7102Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB000005570.32
7103Phospholipid levels in small VLDLGCST900929760.32
7104CancerGCST900860520.32
7105Chronic lymphocytic leukemiaGCST906247380.32
7106Physical activity (Total log acceleration 10pm-12am)GCST900614200.32
7107Cholesteryl esters in LDL (UKB data field 23417)GCST902695140.32
7108FKBP1B levelsGCST904692420.32
7109Physical activity (Total log acceleration 8pm-10pm)GCST900614190.32
7110MAP2 levelsGCST904698530.32
7111REST UKBBICA NET100 1111GCST903869650.32
7112Cholesterol esters in very large HDLGCST905003540.32
7113CRKL/MGLL ratioGCST903142700.32
7114MCEMP1 levelsGCST904698720.32
7115Type 2 diabetesGCST900187060.32
7116Takes medication for Macular Degeneration?GCST904753870.32
7117X-17357 levelsGCST902005500.32
7118KLK8 levelsGCST904254920.32
7119Isoleucine levels (UKB data field 23465)GCST902695620.32
7120IPCEF1/SMAD1 ratioGCST903151850.32
7121Loneliness (standard GWA)GCST902672880.32
7122Colorectal cancerGCST900185880.32
7123GNE levelsGCST904693700.32
7124GGACT levelsGCST904693330.32
7125Saturated fatty acids to total fatty acids percentage (UKB data field 23455)GCST902695520.32
7126rfMRI connectivity (ICA100 edge 380)GCST900052330.31
7127Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455ECGU0004550.31
7128Idiopathic pulmonary fibrosisFING000006590.31
7129HS6ST2 levelsGCST904694800.31
7130Total cholines levelsGCST900928120.31
7131Colorectal cancer, excluding all cancers (controls excluding all cancers)FING000003170.31
7132ANXA4/HSPB1 ratioGCST903132920.31
7133Propionylglycine levelsGCST901997050.31
7134T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209200.31
7135CXCL5 levelsGCST904689320.31
7136ENO2/SULT1A1 ratioGCST903146690.31
7137PCBP2 levelsGCST904701670.31
7138GPD1 levelsGCST904693880.31
7139PTPRR levelsGCST904703860.31
7140aseg rh intensity PallidumGCST900037850.31
7141CAG-269 sp001915995 abundance in stoolGCST900322660.31
7142TNFRSF10B levelsGCST904709000.31
7143Average diameter for LDL particles (UKB data field 23432)GCST902695290.31
7144DTI TBSS L3 Posterior corona radiata RGCST903845500.31
7145red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763650.31
7146MANF levelsGCST904698460.31
7147IDP SWI T2star left caudateGCST900038650.31
7148IL2RA levelsGCST904695850.30
7149Basophil countGCST900022930.30
7150Concentration of medium VLDL particlesGCST904990160.30
7151Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccineGCST904486950.30
7152HPCAL1/MPIG6B ratioGCST903150730.30
7153OLR1 levelsGCST904701220.30
7154Cholesteryl esters in medium LDL (UKB data field 23541)GCST902696380.30
7155Ever taken cannabis | Cannabis useUKBB000002240.30
7156CNP levelsGCST904687980.30
71573-methyl-2-oxovalerate levelsGCST902434850.30
7158PSME1 levelsGCST904703600.30
7159MED18/SH2B3 ratioGCST903154120.30
7160Omega-6 fatty acid levelsGCST905025140.30
7161Lymphoid neoplasms (B-cell phenocluster)GCST906247360.30
7162CEP112 levelsGCST904687080.30
7163AAMDC levelsGCST904681860.30
7164IDP T1 FIRST right caudate volumeGCST900024390.30
7165ACRBP levelsGCST904682050.30
7166Physical activity (Total log acceleration 6am-8am)GCST900614120.30
7167IDP dMRI TBSS MO Retrolenticular part of internal capsule RGCST900039720.30
7168MMP9/OLR1 ratioGCST903154670.30
7169High light scatter reticulocyte countGCST900023850.30
7170High cholesterolGCST904752030.30
7171CD209/ITGAV ratioGCST903137530.30
7172Phospholipids to Total Lipids in Small VLDL percentageGCST904999020.30
7173DBI/TMSB10 ratioGCST903144140.30
7174FADD/PPP1R2 ratioGCST903147740.30
7175Oblique pelvic inlet lengthGCST904489090.30
7176Rheumatoid arthritisGCST900186900.30
7177NUCB2/TRIAP1 ratioGCST903155770.30
7178CD300LG/TNFRSF1A ratioGCST903138030.30
7179Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditionsUKBB000005100.29
7180SRC levelsGCST904707410.29
7181RWDD1 levelsGCST904705100.29
7182Skin yellow/blue componentGCST903202590.29
7183Cabbage likingGCST900947190.29
7184Hernia of abdominal wall, postoperativeFING000006180.29
7185Monocyte countGCST900187470.29
7186GCG levelsGCST904693160.29
7187Dermatophytosis / Dermatomycosis (PheCode 110)GCST904755600.29
7188IDP dMRI ProbtrackX ICVF fmiGCST900043860.29
7189T1 FreeSurfer BA rh BA2 exvivo volumeGCST903855760.29
7190rfMRI connectivity ICA-features 1GCST900063390.29
7191Cholesterol levels in medium HDLGCST900928920.29
7192Accelerometer-based physical activity measurement (average acceleration)GCST0060990.29
7193SRPK2 levelsGCST904707430.29
7194AmygNuclei rh volume Medial-nucleusGCST900026630.29
7195SarcoidosisFING000012750.29
7196Tea without sugar likingGCST900948580.29
7197SH2B3 levelsGCST904706160.29
7198Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurementUKBB000002110.29
7199SPON1 levelsGCST904707310.29
7200KLK7 levelsGCST904697060.29
7201SCAMP3/VPS53 ratioGCST903158070.29
7202DNM1 levelsGCST904690210.29
7203Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473ECGA0004730.29
7204COL3A1 levelsGCST904688170.28
7205GPIHBP1 levelsGCST904693900.28
7206BCR/ICA1 ratioGCST903134930.28
7207IPCEF1/TBCC ratioGCST903151880.28
7208T1 FreeSurfer DK lh superiortemporal thicknessGCST903856510.28
7209PDGFC/TFPI ratioGCST903156360.28
7210Plasma propionylcarnitine (C3) levels in chronic kidney diseaseGCST902658760.28
7211ICAM1 levelsGCST904694980.28
7212Medication use (beta blocking agents)GCST900187660.28
7213ICD10 O20: Haemorrhage in early pregnancyGCST904542350.28
7214Schizophrenia or delusion (more control exclusions)FING000012780.28
7215CFB levelsGCST904687230.28
7216Number of self-reported non-cancer illnesses | Medical conditionsUKBB000005410.28
7217PADI2 levelsGCST904701420.28
7218MSR1 levelsGCST904699500.28
7219RAB31 levelsGCST900875520.28
7220Lymphoid neoplasms (P-cell phenocluster)GCST906247370.28
7221NSFL1C levelsGCST904700890.28
7222Other bacterial diseasesFING000009680.28
7223PDGFB/TIMP3 ratioGCST903156310.28
7224Treatment speciality of consultant (recoded) - Dermatology | Summary AdministrationUKBB000008300.28
7225ACY1 levelsGCST904682120.28
7226USP8/WASF1 ratioGCST903159440.28
7227PLXNA4/SUSD1 ratioGCST903156890.28
7228TBCB levelsGCST904708130.28
7229Otitis media and Eustachian tube disorders (PheCode 381)GCST904759020.28
7230IDP dMRI TBSS ISOVF Posterior corona radiata RGCST900045030.28
7231Cholesterol in small VLDL (UKB data field 23512)GCST902696090.28
7232Sphingomyelin_33:1_[M+H]1+ levelsGCST900602290.28
7233Phospholipids to Total Lipids in Medium VLDL percentageGCST904990430.28
7234LAT/MANF ratioGCST903152840.27
7235CASP7 levelsGCST904685470.27
7236AGER levelsGCST900120540.27
7237Mild age-related type 2 diabetesGCST900264160.27
7238ICD10 N81: Female genital prolapseGCST904542140.27
7239HMBS/PSMG3 ratioGCST903150640.27
7240High light scatter reticulocyte percentage of red cellsGCST900023860.27
7241Gout (PheCode 274.1)GCST904763790.27
7242Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454ECGU0004540.27
7243MAVS/ZBTB16 ratioGCST903154010.27
7244F-burn/spicy liking (derived food-liking factor)GCST900947160.27
7245Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643280.27
7246ENDOU levelsGCST904691070.27
7247Coronary artery plaque burdenGCST905030750.27
7248Certain disorders involving the immune mechanismFING000002640.27
7249KLK6 levelsGCST904697050.27
7250Type 2 diabetes | endocrine/metabolicUKBB000008670.27
7251IDP dMRI TBSS ICVF Pontine crossing tractGCST900043280.27
7252CCN3/COL6A3 ratioGCST903137200.27
7253Omega-3 fatty acids to total fatty acids percentageGCST905024600.27
72541-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996520.27
7255CXCL5/EDAR ratioGCST903143490.27
7256IDP T1 SIENAX grey unnormalised volumeGCST900024310.27
7257LY75 levelsGCST904698220.27
7258ST6GAL1 levelsGCST904707530.27
7259Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903028170.27
7260Serum copper levelsGCST901005240.27
7261Telomere length (principal component 2)GCST904351450.27
7262LBR levelsGCST904697440.27
7263aparc-Desikan rh volume fusiformGCST900028070.27
7264Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479ECGA0004790.27
7265SPINK5 levelsGCST904707240.27
7266Gastric cancerGCST900186290.27
7267Vaginitis/vulvovaginitis/vulvitis/abscess of vulvaFING000014120.26
7268Tyrosine levelsGCST905001560.26
7269EIF4B levelsGCST904690940.26
7270aparc-DKTatlas lh volume parstriangularisGCST900028800.26
7271IGF1 levelsGCST901026230.26
7272Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenumUKBB000006060.26
7273LRG1 levelsGCST904697930.26
7274SPARCL1 levelsGCST904707170.26
7275Lymphoid leukemia, chronic (PheCode 204.12)GCST904756130.26
7276IDP dMRI TBSS L1 FornixGCST900040800.26
7277Melanocytic naevi, other sites/unspecifiedFING000008020.26
7278Triglyceride (52:5) levelsGCST904883200.26
7279FKBP5 levelsGCST904692440.26
7280NECTIN2/TNFRSF1A ratioGCST903155320.26
7281AmygNuclei lh volume Central-nucleusGCST900026520.26
7282RUVBL1 levelsGCST904705090.26
7283Cholesteryl ester (16:2) levelsGCST900246280.26
7284DBNL/EDAR ratioGCST903144160.26
7285Benign neoplasm: Rectum, anus and anal canalFING000001970.26
7286CD27 levelsGCST904686150.26
7287EZR levelsGCST904691620.26
7288GBP2 levelsGCST904693120.26
7289Pancreas volumeGCST900166690.26
7290SCARF1 levelsGCST904705360.26
7291Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST902697230.26
7292Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivityGCST903027240.26
7293IL1RL1 levelsGCST904695740.26
7294Glycated haemoglobin HbA1c levels (UKB data field 30750)GCST904680720.26
7295Melanocytic naeviFING000007970.26
7296Phosphatidylethanolamine (38:4) levelsGCST904882610.26
7297VTA1 levelsGCST904710580.26
7298ADAM12 levelsGCST904682160.26
7299High light scatter reticulocyte percentage | Blood countUKBB000003270.26
7300RNASE3 levelsGCST904704770.26
7301CD200/CNTNAP2 ratioGCST903137470.26
7302MXRA8 levelsGCST904699680.26
7303Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903027190.26
7304potassium (mean, inv-norm transformed)GCST904763070.26
7305ERBB3/IL1R2 ratioGCST903146890.26
7306NPL levelsGCST904700720.26
7307Attention deficit hyperactivity disorderGCST905684410.26
7308DTI TBSS MD Anterior corona radiata LGCST903845950.26
7309CD38/IL12A_IL12B ratioGCST903138080.26
7310aparc-a2009s rh volume G-parietal-supGCST900030250.25
7311Cholesteryl esters in small VLDL (UKB data field 23513)GCST902696100.25
7312Low-density lipoprotein levels (MTAG)GCST901791480.25
7313Lysophosphatidylcholine (20:3) [sn1] levelsGCST900241690.25
7314FOXO1/USP8 ratioGCST903148790.25
7315Cholesteryl Esters in Large LDLGCST904979550.25
7316CLEC14A/PIK3IP1 ratioGCST903140800.25
7317ICAM3/TNFRSF13B ratioGCST903151240.25
7318FBLN2 levelsGCST904691930.25
7319Octadecanedioylcarnitine (C18-DC) levelsGCST901999920.25
7320DNAJA2 levelsGCST904690090.25
7321Treatment/medication code - amlodipine | MedicationsUKBB000008400.25
7322DSC2 levelsGCST904690400.25
7323Non-insulin-dependent diabetes mellitus | Diabetes mellitusUKBB000005240.25
7324Alanine levelsGCST904970860.25
7325BMI (weighted GWA)GCST902672690.25
7326Total lipids in medium LDL (UKB data field 23538)GCST902696350.25
7327DCXR/SCLY ratioGCST903144400.25
7328ATOX1 levelsGCST904683850.25
7329TRIAP1 levelsGCST904709630.25
7330DTI TBSS L3 Anterior corona radiata RGCST903845460.25
7331IL7 levelsGCST904696060.25
7332White blood cell countGCST900187580.25
7333IGSF8 levelsGCST904695400.25
7334CHMP1A levelsGCST904687460.25
7335INPP1/TBCC ratioGCST903151800.25
7336F-sodas liking (derived food-liking factor)GCST900948420.25
7337SNAP25 levelsGCST904706910.25
7338Total diffusion tensor imaging along the perivascular space indexGCST904555460.25
7339T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903208250.25
7340DOK1 levelsGCST904690280.25
7341TBCB/TBCC ratioGCST903159090.25
7342Estimated glomerular filtration rate (cystatin c)GCST904284480.25
7343Body fat percentage (adjusted for testosterone and SHBG) x sex interactionGCST904321810.25
7344CTRB1 levelsGCST904689050.25
7345Phenylacetate levelsGCST901996300.24
7346aparc-DKTatlas rh volume fusiformGCST900028980.24
7347ENPP6 levelsGCST904691170.24
7348ADGRF5 levelsGCST904682390.24
7349Volume of right central nucleusGCST904750270.24
7350CD40 levelsGCST904686330.24
7351NADK levelsGCST904699930.24
7352High density lipoprotein cholesterol levelsGCST902396510.24
7353Total concentration of lipoprotein particles (UKB data field 23427)GCST902695240.24
7354Indolelactate levelsGCST902435070.24
7355Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228ECGU0002280.24
7356ADA2/COMP ratioGCST903131660.24
7357CACNA2D3 levelsGCST902433480.24
7358CTSB levelsGCST904689080.24
7359neutrophil (absolute count, minimum, inv-norm transformed)GCST904755320.24
7360Operative procedures - Total cholecystectomy NEC | Summary OperationsUKBB000005890.24
7361Peptic ulcer diseaseGCST902709260.24
7362TOMM20 levelsGCST904709310.24
7363DLK1/FAP ratioGCST903144910.24
7364ABL1/CC2D1A ratioGCST903131480.24
7365Left-hemisphere control network to pallidum white-matter structural connectivityGCST903027550.24
7366KAZN levelsGCST904696660.24
7367ANPEP levelsGCST904683130.24
7368Free cholesterol levels in very large HDLGCST900930080.24
7369Total lipids in very large HDLGCST905004230.24
7370Creatinine levelsGCST904972360.24
7371Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002660.24
7372CD27/FCRL5 ratioGCST903137720.24
7373DCTN6/TDRKH ratioGCST903144360.24
7374MTIF3 levelsGCST904699570.24
7375Concentration of small VLDL particlesGCST900929750.23
7376Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST906247460.23
7377VASN levelsGCST904710270.23
7378GIPC3 levelsGCST904693480.23
7379T1 FreeSurfer DKT lh superiortemporal thicknessGCST903842520.23
7380CASP8/PRDX6 ratioGCST903136550.23
7381Other diseases of blood and blood-forming organs, wideFING000009990.23
7382ANXA4/FADD ratioGCST903132910.23
7383Phospholipids in small HDL (UKB data field 23574)GCST902696710.23
7384MPI levelsGCST904699360.23
7385End-diastolic bi-ventricular shape (principal component 2)GCST904484810.23
7386Linoleic acid levels (UKB data field 23449)GCST902695460.23
7387rfMRI connectivity (ICA25 edge 103)GCST900047460.23
7388Phospholipid levels in medium HDLGCST900929000.23
7389VLDL cholesterol levelsGCST905001960.23
7390Total lipid levels in small VLDLGCST900929740.23
7391MPO levelsGCST900120310.23
7392IFNGR2 levelsGCST904695140.23
7393Clonal hematopoiesis (DNMT3A mutation)GCST904353540.23
7394GP6 levelsGCST904693840.23
7395DAB2/LYN ratioGCST903143650.23
7396Phosphatidylcholines levels (UKB data field 23437)GCST902695340.23
7397Principal component-derived dietary pattern 46GCST901330510.23
7398MYBPC1 levelsGCST904699690.23
7399CCL21 levelsGCST904685730.23
7400Alanine transaminase (ALT, mean, inv-norm transformed)GCST904751120.23
7401ATXN2L levelsGCST904684020.23
7402Cholesterol in medium LDL (UKB data field 23540)GCST902696370.23
7403CXCL1 levelsGCST904689300.23
7404Congenital malformations of heart and great arteriesFING000003360.23
7405Cardiac dysrhythmias | circulatory systemUKBB000001190.23
7406TFF2 levelsGCST904708360.23
7407EREG/ITGB1BP2 ratioGCST903147030.23
7408Glycoprotein acetyls levels (UKB data field 23480)GCST902695770.23
7409PLXNA4 levelsGCST904702650.23
7410Polyunsaturated fatty acid levelsGCST900929390.23
7411PLIN3 levelsGCST904702590.23
7412RGMB/SMOC2 ratioGCST903157700.22
7413FABP5 levelsGCST904691770.22
7414EIF4G1 levelsGCST904690970.22
7415Physical activityGCST900933240.22
7416Disorders of plasma-protein metabolism, not elsewhere classifiedFING000004550.22
7417Percentage of M9 (GP18)GCST906684620.22
7418Omega-6 fatty acids levels (UKB data field 23445)GCST902695420.22
7419Low density lipoprotein cholesterol levelsGCST900024120.22
7420ITGA5 levelsGCST904696350.22
7421Right ventricular end diastolic volume (MTAG)GCST901345920.22
7422MYOM3 levelsGCST904699860.22
7423Phospholipids in HDL (UKB data field 23414)GCST902695110.22
7424Restless legs syndrome (PheCode 327.71)GCST904758290.22
7425TDP1 levelsGCST904708260.22
7426HBEGF/LAT2 ratioGCST903150320.22
7427Triglycerides in small HDLGCST904995160.22
7428CCL13/CCL17 ratioGCST903136740.22
7429Total concentration of branched-chain amino acids (leucine + isoleucine + valine)GCST900929840.22
7430MAVS/MZT1 ratioGCST903153910.22
7431Triglycerides in very large HDLGCST905004820.22
7432TNFRSF1A levelsGCST904709100.22
7433TIA1 levelsGCST904708620.22
74345alpha-pregnan-3beta,20beta-diol monosulfate (1) levelsGCST901998530.22
7435Cholesteryl Esters in HDLGCST904973570.22
7436Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB000005800.22
7437ITGAV levelsGCST904696390.22
7438VLDL cholesterol levelsGCST900929960.22
7439Essential tremor (PheCode 333.1)GCST904758320.22
7440Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481ECGA0004810.22
7441DPY30 levelsGCST904690370.22
7442Neutrophil countGCST900259770.22
7443CDH17/GALNT3 ratioGCST903139400.22
7444Varicose veins (PheCode 454)GCST904760120.22
7445APOA1 levelsGCST900928080.22
7446CCL4 levelsGCST0044330.22
7447LTBR/SIRPB1 ratioGCST903153390.22
7448Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST904752750.22
7449All pneumoniaeFING000000650.21
7450Hemoglobin concentrationGCST0046150.21
7451HMOX1 levelsGCST904694650.21
7452Total lipid levels in medium HDLGCST900928980.21
7453High light scatter reticulocyte count | Blood countUKBB000003260.21
7454Cholesteryl ester levels in medium HDLGCST900928940.21
7455TNFRSF4/TNFRSF8 ratioGCST903159380.21
7456CDKN1A/HBEGF ratioGCST903139720.21
7457CD46 levelsGCST904686340.21
7458Concentration of medium HDL particlesGCST900928990.21
7459CSRP3 levelsGCST904688920.21
7460Eosinophil countGCST900187330.21
7461Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levelsGCST900602980.21
7462MITD1 levelsGCST904699100.21
7463BLMH/PEAR1 ratioGCST903135190.21
7464GM2A levelsGCST904693650.21
7465High density lipoprotein cholesterol levelsGCST902786350.21
7466Total body bone mineral density (age 0-15)GCST0053450.21
7467Horseradish likingGCST900947830.21
7468TNFRSF11A levelsGCST902776440.21
7469Ever depressed for a whole week | Mental healthUKBB000002140.21
7470TMEM25 levelsGCST904708880.21
7471Total fatty acid levelsGCST905027100.21
7472HSPB1 levelsGCST904694890.21
7473Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500ECGU0005000.21
7474NID2 levelsGCST904700480.21
7475STAT2 levelsGCST904707580.21
7476Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697180.21
7477HEXIM1/TRIAP1 ratioGCST903150540.21
7478CD27/TNFRSF9 ratioGCST903137780.21
7479Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480ECGA0004800.21
7480GOLM2/ITGA5 ratioGCST903149510.21
7481FOXO1/MAP4K5 ratioGCST903148720.21
7482aparc-DKTatlas lh volume supramarginalGCST900028910.21
7483NTRK3 levelsGCST904700980.21
7484MAX levelsGCST904698670.21
7485SNX9 levelsGCST904707030.21
7486HBEGF/PDGFA ratioGCST903150330.21
7487Systolic blood pressureGCST900259680.21
7488Total lipids in HDL (UKB data field 23426)GCST902695230.21
7489Cholesteryl Esters in Small VLDLGCST904997820.21
7490Plasma N-acetylhistidine levels in chronic kidney diseaseGCST902655760.21
7491Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levelsGCST900602430.21
7492Sphingomyelin_40:0_[M+H]1+ levelsGCST900603640.20
7493BIN2/PDLIM7 ratioGCST903135090.20
7494DTI TBSS MD Splenium of corpus callosumGCST903845760.20
7495Haddock likingGCST900947760.20
7496Dried fruit consumptionGCST901329800.20
7497CILP levelsGCST904687540.20
7498Psoriatic arthritis vs Cutaneous psoriasisGCST902439570.20
7499aseg lh intensity Inf-Lat-VentGCST900037650.20
7500NAA80 levelsGCST904699900.20
7501IMPA1 levelsGCST904696100.20
7502BANK1 levelsGCST904684210.20
7503QSOX1 levelsGCST904704020.20
7504MEP1B levelsGCST904698880.20
7505Cholesterol levels in small VLDLGCST900929680.20
7506ALCAM/MSR1 ratioGCST903132400.20
7507Excessive scarringGCST904833680.20
7508MNDA levelsGCST904699270.20
7509CD274 levelsGCST904686130.20
7510Reason for glasses/contact lenses - For 'astigmatism' | EyesightUKBB000007330.20
7511CNTN2 levelsGCST904688040.20
7512Main speciality of consultant (recoded) - Gastroenterology | Summary AdministrationUKBB000004150.20
7513Mineral and other dietary supplements - Fish oil (including cod liver oil) | MedicationUKBB000004720.20
7514Total phospholipid levels in lipoprotein particlesGCST905001240.20
7515CA2/NSFL1C ratioGCST903135800.20
7516C1QTNF9 levelsGCST904684910.20
7517Breathing problems during period of job | Employment historyUKBB000001110.20
7518Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499ECGA0004990.20
7519Venous thromboembolismGCST903997440.20
7520platelet count (maximum, inv-norm transformed)GCST904762960.20
7521NUDT2 levelsGCST904701060.20
7522Homeostasis model assessment of beta-cell functionGCST0051800.20
7523STC2 levelsGCST904707620.20
7524QC SWI-to-T1 linear alignment discrepancyGCST900063520.20
7525JPT2 levelsGCST904696630.20
75264-androsten-3beta,17beta-diol disulfate 2 levelsGCST902438800.20
7527Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary OperationsUKBB000005910.20
7528Free androgen indexGCST902398240.20
7529WWP2 levelsGCST904710800.20
7530HDL x depression interaction (2df test)GCST905706670.19
7531Platelet countGCST900024020.19
7532PTPN6 levelsGCST904703770.19
7533Alzheimer's diseaseGCST900271580.19
7534Age high blood pressure diagnosed | Medical conditionsUKBB000000160.19
7535ELOA levelsGCST904691040.19
7536Personality disorders (more control exclusions)FING000011630.19
7537Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449ECGU0004490.19
7538Endometriosis of ovaryFING000005010.19
7539Frequency of unenthusiasm / disinterest in last 2 weeks | Mental healthUKBB000002700.19
7540SERPINB13 levelsGCST904233260.19
7541Omega-3 fatty acids to total fatty acids percentageGCST904991550.19
7542CXCL11/ITGB1BP2 ratioGCST903143350.19
7543aseg lh volume Lateral-VentricleGCST900026160.19
7544C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST902575700.19
7545MGMT levelsGCST904699020.19
7546C-reactive protein levels (CRP.4337.49.2)GCST902405030.19
7547CD6/EZR ratioGCST903138900.19
7548COMT levelsGCST904688280.19
7549Breast cancer | neoplasmsUKBB000001090.19
7550Strenuous sports or other exercisesGCST0061000.19
7551SERPINA11 levelsGCST904705800.19
7552Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687580.19
7553Phosphoglycerides levelsGCST900929380.19
7554Facial wrinkles (under eye)GCST900949030.19
7555Emotionally unstable personality disorderFING000004950.19
7556CRKL levelsGCST904688670.19
7557Treatment/medication code - gliclazide | MedicationsUKBB000008460.19
7558ANXA3 levelsGCST904683180.19
7559PPP1R2/USP8 ratioGCST903157230.19
7560PDE5A levelsGCST904701870.19
7561ACP6 levelsGCST904682040.19
7562Unstable angina (intermediate coronary syndrome) | circulatory systemUKBB000008830.19
7563DTI autoptx L1 cst l tractGCST903851470.19
7564Total concentration of lipoprotein particlesGCST900929900.19
7565EDAR/EGF ratioGCST903145730.19
7566Right-hemisphere control network to putamen white-matter structural connectivityGCST903028380.19
7567CANT1/ROR1 ratioGCST903136200.19
7568aparc-pial rh area fusiformGCST900031800.19
7569Red cell distribution width varianceGCST905657050.19
7570CA9 levelsGCST904685180.18
7571Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020750.18
7572PLA2G10 levelsGCST904702440.18
7573Glucose levelsGCST900928190.18
7574Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004870.18
7575CD5/CD6 ratioGCST903138600.18
7576F-fatty food liking (derived food-liking factor)GCST900947610.18
7577GPRC5C levelsGCST904693980.18
7578LACTB2 levelsGCST904697260.18
7579EDAR/ENO2 ratioGCST903145740.18
7580Duodenal ulcerGCST902709280.18
7581rfMRI connectivity ICA-features 6GCST900063440.18
7582Rotator cuff injuryGCST900447000.18
7583CACNB3 levelsGCST904685230.18
7584Other diseases of blood and blood-forming organsFING000009980.18
7585GAL levelsGCST904693000.18
7586Childhood body mass indexGCST900024090.18
7587Verbal-numerical reasoningGCST0034980.18
7588Temporomandibular joint disordersFING000013540.18
7589wg lh intensity-contrast frontalpoleGCST900038230.18
7590ATG16L1 levelsGCST904683830.18
7591BA-exvivo rh thickness BA2GCST900035280.18
7592Reticulocyte percentage (UKB data field 30240)GCST904681010.18
7593DTI autoptx L2 ifo l tractGCST903851780.18
7594aparc-pial lh area supramarginalGCST900031710.18
7595CXCL14 levelsGCST904689270.18
7596CholelithiasisFING000002750.18
7597Enthesopathy (PheCode 726.1)GCST904762390.18
7598CDH17/DSG2 ratioGCST903139390.18
7599Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3ECGA0000030.18
7600rfMRI amplitudes (ICA100 node 38)GCST900046260.18
7601Plasma 4-guanidinobutanoate levels in chronic kidney diseaseGCST902646200.18
7602T1 FreeSurfer aseg 4th-VentricleGCST903841480.18
7603BA-exvivo lh area BA6GCST900032130.18
7604DAG1/HBEGF ratioGCST903143760.18
7605RAP1A levelsGCST904704250.18
7606SNX2 levelsGCST904707010.18
7607Red blood cell countGCST900024030.18
7608Triglycerides in small HDLGCST904995190.18
7609Saturated fatty acids to total fatty acids percentageGCST904999660.18
7610CD58/LTBR ratioGCST903138510.18
7611MAP3K5/MAVS ratioGCST903153790.18
7612DCTN1 levelsGCST904689580.18
7613GRP levelsGCST902412420.18
7614Treatment/medication code - co-codamol | MedicationsUKBB000008450.17
7615Cervicalgia (PheCode 761)GCST904762670.17
7616CD58/TYRO3 ratioGCST903138560.17
7617HDL cholesterol levelsGCST904973400.17
7618Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10ECGA0000100.17
7619Red blood cell erythrocyte count (UKB data field 30010)GCST904680980.17
7620Linoleic acid levelsGCST900928800.17
7621Malignant neoplasm of female breast (PheCode 174.11)GCST900418330.17
7622HSIL lesion of the vulvaFING000006260.17
7623Fluid intelligence score decline (difference score)GCST905658620.17
7624Age spotsGCST0060960.17
7625F-chocolate/coffee liking (derived food-liking factor)GCST900947350.17
7626CD84/SEMA4D ratioGCST903139170.17
7627Smoked fish likingGCST900948410.17
7628Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497ECGU0004970.17
7629ANPEP/DPP4 ratioGCST903132730.17
7630RNF43 levelsGCST904704860.17
7631Omega-6 fatty acids to total fatty acids percentageGCST904992100.17
7632PRRT3 levelsGCST904703400.17
7633Docosahexaenoic acid to total fatty acids percentageGCST905022850.17
7634PECAM1/SOD2 ratioGCST903156470.17
7635NIT2 levelsGCST904700510.17
7636Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427ECGU0004270.17
7637CDH5 levelsGCST904686760.17
7638CD69/EDAR ratioGCST903138750.17
7639PDGFC levelsGCST904701900.17
7640Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4ECGA0000040.17
7641EBAG9 levelsGCST904690590.17
7642WFIKKN1 levelsGCST904710760.17
7643KL levelsGCST900912460.17
7644EIF4G1/FOXO1 ratioGCST903146340.17
7645PODXL2/SDC1 ratioGCST903157010.17
7646T1 FreeSurfer a2009s rh G cuneus volumeGCST903850480.17
7647ACVRL1/TNFRSF19 ratioGCST903131590.16
7648Flat foot (PheCode 735.1)GCST904762480.16
7649ICAM3/LY9 ratioGCST903151210.16
7650TBCC/WWP2 ratioGCST903159110.16
7651Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900241970.16
7652FGF23 levelsGCST904692230.16
7653End stage renal disease (PheCode 585.32)GCST904761260.16
7654Omega-6 fatty acid levelsGCST905025020.16
7655BRAP levelsGCST904684640.16
7656wg lh intensity-contrast parsorbitalisGCST900038100.16
7657BTC levelsGCST904684760.16
7658DYNLT1 levelsGCST904690570.16
7659IDP T1 FAST ROIs L thalamusGCST900025470.16
7660IDP dMRI TBSS L1 Retrolenticular part of internal capsule RGCST900040950.16
7661IL18 levelsGCST904284110.16
7662Triglycerides to total lipids ratio in large HDLGCST900928550.16
7663ITGA6/THPO ratioGCST903152080.16
7664LEPR/NTRK2 ratioGCST903153130.16
7665Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498ECGU0004980.16
7666OtosclerosisGCST901295750.16
7667NFASC levelsGCST904700310.16
7668VAMP5 levelsGCST904710240.16
7669CPB1/KIRREL2 ratioGCST903142100.16
7670Polyunsaturated fatty acid levelsGCST905026060.16
7671DepressionFING000003980.16
7672CCER2 levelsGCST904685630.16
7673MIF levelsGCST904699060.16
7674Cholesteryl Esters in VLDLGCST905002110.16
7675CCL25/PRSS27 ratioGCST903136940.16
7676TMED8 levelsGCST904708850.16
7677OXCT1 levelsGCST904701380.16
7678T1 FreeSurfer DK lh precentral thicknessGCST903856450.16
7679MAPK13 levelsGCST902419490.16
7680SCAMP3 levelsGCST904705320.16
7681AGRP levelsGCST900120630.16
7682APOA2 levelsGCST904683320.16
7683IDP dMRI TBSS MD Posterior limb of internal capsule LGCST900040460.16
7684VWC2 levelsGCST904710640.16
7685Cholesterol levels in very large HDLGCST900930040.16
7686Gout, strict definitionFING000005880.16
7687HematocritGCST0046040.16
7688MSR1/TNFRSF21 ratioGCST903154940.16
7689X-12411 levelsGCST902004920.15
7690PLA2G7 levelsGCST904702490.15
7691FCN1 levelsGCST906185650.15
7692PYDC1 levelsGCST904703970.15
7693Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903027060.15
7694Postinfectious hypothyroidismFING000011920.15
7695Concentration of HDL particlesGCST900928260.15
7696NPTX2 levelsGCST904700790.15
7697Blood cell traits latent factor 4 (red cell)GCST905592460.15
7698SUMF2 levelsGCST904707840.15
7699Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900250560.15
7700PCDH17/THBD ratioGCST903156070.15
7701Obesity, other/unspecifiedFING000008980.15
7702Cholesteryl Esters in Small LDLGCST904995780.15
7703GRSF1 levelsGCST904694070.15
7704C1S levelsGCST904684940.15
7705Cholesterol in Large HDLGCST904977190.15
7706Free cholesterol in medium HDLGCST904985630.15
7707Platelet count (UKB data field 30080)GCST904680950.15
7708CSNK1D levelsGCST904688880.15
7709Effects radiation NOS (PheCode 990)GCST904762930.15
7710KeratoconusFING000007090.15
7711aparc-Desikan lh volume supramarginalGCST900027980.15
7712JAM2/TNFRSF21 ratioGCST903152420.15
7713Octadecenedioylcarnitine (C18:1-DC) levelsGCST901999700.15
7714DVT of lower extremitiesFING000004820.15
7715neutrophil (absolute count, mean, inv-norm transformed)GCST904755290.15
7716PlateletcritGCST900024000.15
7717B4GAT1 levelsGCST904684130.15
7718CDH6 levelsGCST904686770.15
7719CD6 levelsGCST904686440.15
7720Dermatitis due to ingested foodFING000004030.15
7721TPD52L2 levelsGCST904709420.15
7722Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903028110.15
7723CPB1/CTRC ratioGCST903142090.15
7724wg rh intensity-contrast postcentralGCST900038480.15
7725Aspartate aminotransferase levelsGCST902786180.15
7726Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB000003740.15
7727KeloidGCST906524880.15
7728triglyceride (mean, inv-norm transformed)GCST904764350.15
7729NUDT16 levelsGCST904701050.15
7730CDHR2/MME ratioGCST903139630.15
7731FOXO1/IRAK4 ratioGCST903148700.15
7732Operation code - hip replacement/revision | OperationsUKBB000005580.15
7733Polyunsaturated fatty acids to total fatty acids percentageGCST904993020.15
7734CoxarthrosisFING000003620.15
7735GPLD1 levelsGCST900868900.15
7736ICD10 O42: Premature rupture of membranesGCST904542380.15
7737Right-hemisphere control network to accumbens white-matter structural connectivityGCST903028420.15
7738Major dietary changes in the last 5 years - Yes, because of illness | DietUKBB000004220.15
7739aparc-DKTatlas lh area supramarginalGCST900032630.15
7740aparc-DKTatlas rh thickness postcentralGCST900035910.15
7741Gestational age at birth (maternal effect)GCST902684190.15
7742Leisure/social activities - None of the above | Social supportUKBB000003990.15
7743Parental longevity (combined parental age at death)GCST0067020.15
7744F3 levelsGCST900120140.15
7745MNX1 levelsGCST900907580.15
7746Platelet count | Blood countUKBB000006460.15
7747CDC37/PPP1R12A ratioGCST903139340.14
7748SULT1A1 levelsGCST904707810.14
7749Omega-6 fatty acid levelsGCST905020940.14
7750(R)-3-hydroxybutyrylcarnitine levelsGCST901999300.14
7751ERBB4/NELL1 ratioGCST903146910.14
7752Free cholesterol in large HDLGCST904977860.14
7753Renal failure (PheCode 585)GCST904761180.14
7754AIFM1 levelsGCST904682680.14
7755IFIH1 levelsGCST904236890.14
7756CCL8 levelsGCST904685860.14
7757DKK3 levelsGCST904689980.14
7758aseg rh volume PallidumGCST900026400.14
7759NPDC1/PTGDS ratioGCST903155490.14
7760Triacylglycerol (54:0) [NL-18:0] levelsGCST900251730.14
7761COL18A1 levelsGCST904688120.14
7762S100A4 levelsGCST904705180.14
7763CASP10/PRTFDC1 ratioGCST903136270.14
7764Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023960.14
7765CHGA levelsGCST902406990.14
7766IL18R1 levelsGCST902416070.14
7767SLC9A3R1 levelsGCST904706650.14
7768EHD3 levelsGCST904690890.14
7769T1 CAT volume R TemporalFusiformCortexposteriordivisionGCST903840750.14
7770SELPLG levelsGCST900120460.14
7771CRADD/SIRT2 ratioGCST903142430.14
7772wg lh intensity-contrast lateralorbitofrontalGCST900038030.14
7773Platelet countGCST0046030.14
7774Alanine transaminase (ALT, minimum, inv-norm transformed)GCST904751150.14
7775Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391ECGU0003910.14
7776rfMRI connectivity (ICA100 edge 495)GCST900053480.14
7777ROBO2 levelsGCST904704900.14
7778LEPR levelsGCST904697560.14
7779EFEMP1/TGFBR3 ratioGCST903145970.14
7780EDAR/SERPINB1 ratioGCST903145860.14
7781EIF4G1/FKBP5 ratioGCST903146330.14
7782DTI TBSS L3 Splenium of corpus callosumGCST903845280.14
7783PGLYRP2 levelsGCST904702200.14
7784VCAM1 levelsGCST904710310.14
7785Triglycerides to Total Lipids in Small HDL percentageGCST904995430.14
7786Degree of unsaturationGCST905022300.14
7787Monocyte countGCST900023410.14
7788DTI autoptx L1 slf r tractGCST903851610.14
7789IL18R1 levelsGCST904695650.14
7790GCC1 levelsGCST904693150.14
7791AGRP/CCN1 ratioGCST903132020.14
7792PPP1R2 levelsGCST904703040.14
7793GLOD4 levelsGCST904693590.14
7794PPP3R1 levelsGCST904703070.14
7795PTPN6/SNAP23 ratioGCST903157470.14
7796PTGES2 levelsGCST904703690.14
7797Sleep disorders (combined)FING000013110.14
7798Acute osteomyelitis (PheCode 710.11)GCST904762220.14
7799Caries in Clefts patientsFING000002560.14
7800RTN4R levelsGCST904705080.14
7801LZTFL1 levelsGCST904698340.14
7802COL6A3/SPON2 ratioGCST903141790.14
7803DTI TBSS MD Posterior limb of internal capsule LGCST903845910.14
7804Docosahexaenoic acid levelsGCST904972520.14
7805F5 levelsGCST904464660.13
7806IGFBP4 levelsGCST904695300.13
7807CLEC10A levelsGCST904687630.13
7808CRTAM/ICAM3 ratioGCST903142760.13
7809GUCA2A levelsGCST904694180.13
7810SPINK2 levelsGCST904707220.13
7811aparc-Desikan lh area supramarginalGCST900031030.13
7812CSNK1G2 levelsGCST902406080.13
7813T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95)GCST903206580.13
7814platelet count (mean, inv-norm transformed)GCST904762990.13
7815DNM3 levelsGCST904690220.13
7816SNCG levelsGCST904706950.13
7817CD27/DLL1 ratioGCST903137710.13
7818Multiple system atrophyGCST904069250.13
7819Triacylglycerol_51:3_[M+NH4]1+ levelsGCST900604940.13
7820NeurociticismGCST0069400.13
7821Other disorders of skin and subcutaneous tissue, not elsewhere classifiedFING000010360.13
7822KLK4 levelsGCST904697040.13
7823F7/F9 ratioGCST903147430.13
7824Disorders of choroid and retinaFING000004380.13
7825CHIT1 levelsGCST904687440.13
7826Total lipid levels in small HDLGCST900929500.13
7827Microalbumin urineGCST902786390.13
7828TXLNA levelsGCST904709890.13
7829Estimated glomerular filtration rate (creatinine, cystatin c)GCST904284460.13
7830REST UKBBICA NODEamps25 0021GCST903855040.13
7831KLK11 levelsGCST900120120.13
7832APOA levelsUKBB000000400.13
7833PPIB levelsGCST904702910.13
7834FCRL3 levelsGCST904692070.13
7835Volume of right anterior amygdaloid areaGCST904750000.13
7836Omega-3 fatty acid levelsGCST905024360.13
7837CD274/EFNA4 ratioGCST903137680.13
7838HDL cholesterolGCST900187360.13
7839GP1BA/HBEGF ratioGCST903149560.13
7840Sphingomyelins levelsGCST904999830.13
7841NELL2/SEZ6L ratioGCST903155360.13
7842Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024110.13
7843LSP1/NADK ratioGCST903153310.13
7844Phosphatidylcholine diacyl C36:4 levelsGCST902400400.13
7845NRP1 levelsGCST904700850.13
7846KLK1 levelsGCST904697020.13
7847Varicose veins of lower extremity (PheCode 454.1)GCST904760130.13
7848LAT levelsGCST904697410.13
7849CTSF levelsGCST904689120.13
7850CEBPB levelsGCST904687000.12
7851IDP dMRI ProbtrackX FA cgc rGCST900039300.12
7852PODXL2/SEZ6L ratioGCST903157020.12
78531-stearoylglycerophosphoethanolamine levelsGCST902437800.12
7854AmygNuclei lh volume Cortical-nucleusGCST900026540.12
7855F2R levelsGCST904691680.12
7856Myeloid white cell countGCST0046260.12
7857Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST902660400.12
7858DKK4/REG1A ratioGCST903144890.12
7859Cholesteryl ester levels in small VLDLGCST900929700.12
7860CST6 levelsGCST904688960.12
7861GLB1/GUSB ratioGCST903149310.12
7862White blood cell countGCST902786470.12
7863Triacylglycerol_49:3_[M+NH4]1+ levelsGCST900604430.12
7864CD2AP/USP8 ratioGCST903137840.12
7865FADD/MGLL ratioGCST903147680.12
7866MANSC1 levelsGCST904698470.12
7867MEPE/SOST ratioGCST903154200.12
7868PTPRZ1 levelsGCST904703880.12
7869Triglycerides to total lipids in large VLDL percentage (UKB data field 23593)GCST902696900.12
7870CD40LG/GP6 ratioGCST903138220.12
7871PTPRF levelsGCST904703810.12
7872Triglycerides in very large HDLGCST905004810.12
7873CRHBP levelsGCST904688600.12
7874platelet count (minimum, inv-norm transformed)GCST904763020.12
7875Phenylalanine levelsGCST900929360.12
7876wg rh intensity-contrast medialorbitofrontalGCST900038400.12
7877Mean corpuscular hemoglobinGCST900023900.12
7878T1 FreeSurfer DKT lh precentral thicknessGCST903842460.12
7879Oranges likingGCST900948070.12
7880Triglyceride levels in very large HDLGCST900930140.12
7881Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney diseaseGCST902660450.12
7882SFTPA1 levelsGCST904706120.12
7883EGFL7 levelsGCST904690830.12
7884OTUD7B levelsGCST904701370.12
7885RUNX3 levelsGCST902427060.12
7886HGS levelsGCST904694500.12
7887Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activityUKBB000008710.11
7888Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney diseaseGCST902656710.11
7889DPT levelsGCST904690360.11
7890FXN levelsGCST904692820.11
7891Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428ECGU0004280.11
7892SEMA3G levelsGCST902427460.11
7893Enthesopathies of lower limb, excluding footFING000005090.11
7894Treatment/medication code - quinine | MedicationsUKBB000008550.11
7895EDAR/IPCEF1 ratioGCST903145780.11
7896Alanine aminotransferase levelsGCST900259790.11
7897Redundant prepuce, phimosis and paraphimosisFING000012460.11
7898Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451ECGU0004510.11
7899SERPINI1 levelsGCST904706020.11
7900EDAR/PRDX5 ratioGCST903145830.11
7901NT5C3A levelsGCST904700910.11
7902NOTCH1/SEMA7A ratioGCST903155450.11
7903ROR1/TNFRSF21 ratioGCST903157870.11
7904aparc-DKTatlas lh area fusiformGCST900032390.11
7905Vegetable intake (standard GWA)GCST902673060.11
7906Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST902001030.11
7907Free cholesterol to total lipids ratio in medium HDLGCST900928970.11
7908Juvenile arthritis (FINNGEN)FING000007040.11
7909estimated glomerular filtration rate (eGFR, mean, inv-norm transformed)GCST904752820.11
7910Reticulocyte percentage | Blood countUKBB000007530.11
7911Epstein-Barr virus EA-D antibody levelsGCST900068980.11
7912FGFR4 levelsGCST904692340.11
7913Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991990.11
7914ANXA3/EDAR ratioGCST903132800.11
7915Mean volume of bilateral amygdalaGCST904749970.11
7916TGFBR2/TNFRSF19 ratioGCST903159170.11
7917COL2A1 levelsGCST904688160.11
7918Right-hemisphere visual network to amygdala white-matter structural connectivityGCST903027860.11
7919AKT2 levelsGCST904682770.11
7920wg lh intensity-contrast precentralGCST900038150.11
7921Extrapyramidal and movement disordersFING000005270.11
7922creatinine (mean, inv-norm transformed)GCST904752290.11
7923CD200R1/CLEC4G ratioGCST903137480.11
7924Ulcerative colitis (strict) with PSCFING000013890.11
7925Addison's diseaseGCST900118710.11
7926SIRPB1 levelsGCST904706400.11
7927Eye problems/disorders - None of the above | EyesightUKBB000002320.11
7928DIPK2B levelsGCST904689960.11
7929Eosinophil countGCST900022990.11
7930Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST902697210.11
7931Other benign neoplasms of skinFING000009710.11
7932Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney diseaseGCST902652740.11
7933Principal component-derived dietary pattern 12GCST901330170.11
7934ATG4A/TPMT ratioGCST903133700.11
7935Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2ECGA0000020.11
7936CHMP1A/EREG ratioGCST903140480.11
7937SCARF2 levelsGCST904705370.11
7938Phospholipids to Total Lipids in Very Large HDL percentageGCST905004720.11
7939Hair/balding pattern: Pattern 1 (UKB data field 2395_1)GCST900436160.11
7940Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394ECGU0003940.11
7941Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390ECGU0003900.11
7942Glycine levelsGCST904973150.11
7943SFRP1 levelsGCST904706100.11
7944Phospholipids in large LDLGCST904980530.11
7945Blood cell traits latent factor 16 (white cell)GCST905592580.11
79465alpha-androstan-3alpha,17beta-diol monosulfate (1) levelsGCST901998580.11
7947Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1ECGA0000010.11
7948Alanine levels (UKB data field 23460)GCST902695570.11
7949PFDN5 levelsGCST902423400.11
7950Volume of right whole amygdalaGCST904750570.11
7951Creatinine levels in bottom 99% of individuals by creatinine levelsGCST905667330.11
7952HBEGF levelsGCST904694330.11
7953CEACAM8 levelsGCST904686980.11
7954Left-hemisphere control network to thalamus white-matter structural connectivityGCST903027520.11
7955Cholesteryl esters to total lipids ratio in small HDLGCST900929470.11
7956wg rh intensity-contrast lateraloccipitalGCST900038370.10
7957CMC1 levelsGCST904687940.10
7958IDP dMRI TBSS L1 Sagittal stratum RGCST900041050.10
7959potassium (maximum, inv-norm transformed)GCST904763040.10
7960X-18601 levelsGCST902435010.10
7961LCN2 levelsGCST904697470.10
7962Right ventricular end diastolic volumeGCST901345880.10
7963Functional dyspepsiaFING000005610.10
7964FCRL2/TNFRSF13B ratioGCST903148010.10
7965Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392ECGU0003920.10
7966Disorders of eyelid, lacrimal system and orbitFING000004390.10
7967aparc-DKTatlas lh thickness paracentralGCST900035550.10
7968Sum neutrophil eosinophil countsGCST0046130.10
7969Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393ECGU0003930.10
7970Phospholipids in small LDLGCST904996810.10
7971GP1BA levelsGCST904693800.10
7972Other and unspecified psoriasisFING000009500.10
7973BA-exvivo lh thickness BA4pGCST900035180.10
7974BACH1/PDLIM7 ratioGCST903134450.10
7975MSRA levelsGCST904699510.10
7976CASP3/CRKL ratioGCST903136310.10
7977IL1RN/LGALS9 ratioGCST903151600.10
7978BLNK levelsGCST904684480.10
7979FAM172A levelsGCST904691840.10
7980aseg lh intensity Accumbens-areaGCST900037740.10
7981CDSN levelsGCST904686880.10
7982Docosahexaenoic acid to total fatty acids percentageGCST904972700.10
7983Left-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903027400.10
7984APOA1 levelsGCST904683310.10
7985Blood urea nitrogen levelsGCST902786230.10
7986DTI autoptx FA ptr l tractGCST903851310.10
7987CD244 levelsGCST904686110.10
7988AK2 levelsGCST904682700.10
7989Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental healthUKBB000003380.10
7990ANXA1 levelsGCST904683160.10
7991Mean corpuscular haemoglobin | Blood countUKBB000004470.10
7992IDP dMRI TBSS ISOVF Posterior corona radiata LGCST900045040.10
7993T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST903206090.10
7994DCTD levelsGCST904689570.10
7995Goat cheese likingGCST900947730.10
7996TMEM106A levelsGCST904708860.10
7997Influenza and pneumoniaFING000006790.10
7998Reticulocyte fraction of red cellsGCST900024060.10
7999aseg global volume CC-CentralGCST900026090.10
8000CXCL17 levelsGCST904689290.10